ALDX vs BIIB: Which Stock is Better?
Side-by-side comparison of Aldeyra Therapeutics Inc and Biogen Inc in 2026
ALDX
Aldeyra Therapeutics Inc
$1.42
BIIB
Biogen Inc
$182.31
Key Metrics Comparison
| Metric | ALDX | BIIB | Winner |
|---|---|---|---|
| Market Cap | $74.63M | $26.76B | BIIB |
| P/E Ratio | N/A | 20.74 | BIIB |
| EPS (TTM) | $N/A | $8.79 | BIIB |
| Revenue Growth | 0.0% | -0.1% | BIIB |
| Gross Margin | 0.0% | 78.9% | BIIB |
Analyze ALDX
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ALDX or BIIB a better investment?
Comparing ALDX and BIIB: Aldeyra Therapeutics Inc has a market cap of $74.63M while Biogen Inc has $26.76B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ALDX and BIIB?
ALDX (Aldeyra Therapeutics Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ALDX or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ALDX or BIIB?
ALDX has higher revenue growth at 0.0% vs -0.1% for BIIB.
Which company is more profitable: ALDX or BIIB?
Biogen Inc (BIIB) has higher gross margins at 78.9% compared to 0.0% for ALDX.
Which is the larger company: ALDX or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $26.76B compared to $74.63M for ALDX.
Should I buy ALDX or BIIB in 2026?
Both ALDX and BIIB have investment merit. ALDX trades at $1.42 while BIIB trades at $182.31. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ALDX and BIIB stock?
Key differences: Market Cap ($74.63M vs $26.76B), P/E Ratio (N/A vs 20.7x), Revenue Growth (0.0% vs -0.1%), Gross Margin (0.0% vs 78.9%).